Biodyne Co., Ltd. (KOSDAQ:314930)

South Korea flag South Korea · Delayed Price · Currency is KRW
12,050
-240 (-1.95%)
At close: Apr 28, 2026
-20.36%
Market Cap 358.66B
Revenue (ttm) 4.98B
Net Income (ttm) -78.64M
Shares Out 29.76M
EPS (ttm) -2.64
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 74,743
Average Volume 51,367
Open 12,210
Previous Close 12,290
Day's Range 12,040 - 12,390
52-Week Range 10,480 - 18,420
Beta 1.37
RSI 44.97
Earnings Date n/a

About Biodyne

Biodyne Co., Ltd. engages in the development, manufacture, and sale of liquid-based cytology (LBC) equipment and reagent kits for cancer diagnosis in South Korea. The company offers PATHPLORER solution, which preserves and fixes the collected cells; PATHPLORER LBC system, an equipment for processing liquid cytology samples for cancer diagnosis. It exports its products to Japan, Russia, Portugal, Thailand, and internationally. The company was founded in 1999 and is headquartered in Seoul, South Korea. [Read more]

Industry Surgical and Medical Instruments and Apparatus
Founded 1999
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 314930
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.